NAUT
#3884
Nautilus Biotechnology, Inc. - Common Stock
0.8 9 USD
-0.01%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-1.11%
Monthly Change
-14.42%
6 month change
-61.47%
Year Change
+30.88%
Previous Close
0.9 0
Open
0.8 9
Low
0.8 9
High
0.8 9
Volume
34
Financials
- Market Capitalization 113.26 M
- Employee 130
- Founded 2016
- CEO N/A
- Website www.nautilus.bio
- Headquarter Washington, United States
- FIGI BBG00W7G4M12
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-4.15
Price to sales ratio
—
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3870 |  ANIX Anixa Biosciences, Inc. - Common Stock | 3.48 USD | -3.33% | -4.92% | 0.00% | +17.57% | 118.40 M USD | ||
| 3874 |  RANI Rani Therapeutics Holdings, Inc. - Class A Common Stock | 0.84 USD | -1.18% | -5.62% | -1.18% | +68.00% | 117.09 M USD | ||
| 3897 |  ONCY Oncolytics Biotech Inc. - Common Stock | 0.86 USD | +1.18% | +2.38% | +13.16% | -17.31% | 109.66 M USD | ||
| 3898 |  SEER Seer, Inc. - Class A Common Stock | 1.98 USD | -1.49% | -3.88% | -4.35% | -3.41% | 109.64 M USD |
Frequently asked questions about Nautilus Biotechnolgy, Inc. Common Stock
What is the Nautilus Biotechnolgy, Inc. Common Stock stock price today?
The current price of Nautilus Biotechnolgy, Inc. Common Stock (NAUT) is 0.89. Over the past 24 hours, the stock has changed by -1.11%. Follow the NAUT chart for real-time price dynamics.
What is the stock ticker of Nautilus Biotechnolgy, Inc. Common Stock?
Nautilus Biotechnolgy, Inc. Common Stock trades under the ticker NAUT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Nautilus Biotechnolgy, Inc. Common Stock stock going up?
NAUT has changed by -8.25% over the last week, -14.42% over the last month, and +30.88% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Nautilus Biotechnolgy, Inc. Common Stock?
Nautilus Biotechnolgy, Inc. Common Stock currently has a market capitalization of 113.26 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Nautilus Biotechnolgy, Inc. Common Stock earnings last quarter?
Last quarter, Nautilus Biotechnolgy, Inc. Common Stock reported earnings of -0.11 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Nautilus Biotechnolgy, Inc. Common Stock revenue for the last quarter?
Nautilus Biotechnolgy, Inc. Common Stock reported quarterly revenue of 190 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Nautilus Biotechnolgy, Inc. Common Stock net income for the last quarter?
Nautilus Biotechnolgy, Inc. Common Stock reported net income of 14.47 M for the last quarter. The previous quarter showed -14.7 M, which means net income changed by +198.45%.
How many employees does Nautilus Biotechnolgy, Inc. Common Stock have?
As of the latest available data, Nautilus Biotechnolgy, Inc. Common Stock has 130 employees. Workforce size can provide additional context about the company's scale and operations.
What is Nautilus Biotechnolgy, Inc. Common Stock EBITDA?
Nautilus Biotechnolgy, Inc. Common Stock EBITDA is -15.46 M, and its EBITDA margin is -8 138.42%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Nautilus Biotechnolgy, Inc. Common Stock stock?
You can buy Nautilus Biotechnolgy, Inc. Common Stock (NAUT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Nautilus Biotechnolgy, Inc. Common Stock stock?
Investing in Nautilus Biotechnolgy, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the NAUT chart and related analysis on metatrader.com as part of your research.